Navigation Links
SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
Date:1/6/2009

company developing protein-based pharmaceuticals using its proprietary protein production technology. This technology enables the production of therapeutic proteins in plant seeds by genetically enhancing the safflower plant. SemBioSys' lead pharmaceutical candidates are recombinant human insulin, which is intended to serve the rapidly expanding global diabetes market, and Apo AI(Milano). Apo AI(Milano) is a variant of Apo AI, the major protein associated with high density lipoprotein (HDL), or "good cholesterol", whose function is to remove excess cholesterol from arteries. In addition to its pharmaceutical products, SemBioSys' subsidiary, Botaneco Specialty Ingredients Inc., is selling oleosome-based all natural products in the global personal care ingredient market. More information is available and can be accessed at www.sembiosys.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions and market size, the acceptance of an IND by the FDA in respect of clinical studies, the submission of a CTA to the appropriate European authorities, the successful initiation and timely and successful completion of clinical studies, the fact that Apo AI is currently a development stage drug, the establishment of corporate alliances, the impact of competitive products and pricing, new pro
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys begins phase I/II trial of insulin produced in plant seeds
2. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
3. SemBioSys announces second quarter 2008 financial and operational results
4. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
5. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
6. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
7. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
8. SemBioSys announces first quarter 2008 financial and operational results
9. SemBioSys receives milestone payments from AVAC Ltd.
10. SemBioSys initiates toxicology study for safflower-produced insulin
11. SemBioSys announces 2007 financial and operational results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 ENVIRON , an ... today that Dr. Harvey Clewell III has rejoined ... work closely with senior professionals in ENVIRON’s Health ... serve at The Hamner Institutes for Health Sciences ... where he is Director, Center for Human Health ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The report ... Chemicals), by Application (Cosmetics & Toiletries, and Soaps & ... to 2019”, has defined and segmented the Fragrance Ingredients ... trends in terms of value. The market has been ... North America, Europe, Asia-Pacific, Latin America, and Rest of ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 2014 ... HCL Industry” is a professional and in-depth research ... provides basic Naltrexone HCL information, including its definition, ... as industry overview. This research covers the international ... as global industry analysis covering macroeconomic environment & ...
(Date:10/30/2014)... 2014 James Sherley says he has been ... stem cell technology since his days as a principal investigator ... the late 1990’s. Sherley founded the ASCTC as a ... all the intellectual property developed in Sherley’s research over the ... Institute of Technology (MIT), and more recently as a senior ...
Breaking Biology Technology:Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 2Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON 3Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 2Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 3Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 4Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 5Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4
... Aug. 29 Pharmos Corporation,(Nasdaq: PARS ) ... will,cease operations in Rehovot, Israel, and manage those ... US headquarters in Iselin, New,Jersey., The research ... library,of compounds, including preclinical development of PRS-639,058 for,neuropathic ...
... SAN DIEGO, Aug. 28 Orexigen(R) Therapeutics,Inc. (Nasdaq: ... central nervous system disorders, including obesity, today announced,that the ... BioCentury Newsmakers in the Biotech Industry ... Millennium Broadway Hotel, New York, UBS Global Life ...
... Enerkem Inc., a leading second,generation biofuels technology ... Vice-Presidents to its executive team: Mr. Denis ... Labrie,Vice-President, Government Affairs and Communications., "I ... to our management,team," said Mr. Vincent Chornet, ...
Cached Biology Technology:Pharmos Corporation Announces That it Will Cease Operations in Israel 2Enerkem Expands Executive Management Team 2
(Date:10/31/2014)... Dr. John Schoggins , Assistant Professor of Microbiology at ... Innovator Award from the National Institutes of Health (NIH) ... harbor numerous viruses without becoming sick. , Dr. ... one of 85 awards given under the High Risk/High ... New Innovator Awards were created to support highly creative ...
(Date:10/31/2014)... key steps involved in programmed cell death, offering new ... and neurodegenerative diseases. , The research teams from ... discover the three-dimensional structure of a key cell death ... how it causes cell death. Their studies were published ... Proceedings of the National Academy of Sciences ...
(Date:10/31/2014)... Oct. 30, 2014  HITLAB SM , a ... announce its inaugural HITLAB Innovators Summit SM ... Library. HITLAB will partner with the Clinton Foundation,s ... Health, ProtoHack, Columbia Business School Alumni Club of ... Industrial Engineering and Operations Research, bringing together leaders ...
Breaking Biology News(10 mins):UT Southwestern Microbiologist awarded prestigious NIH research grant 2A matter of life and death: Cell death proteins key to fighting disease 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3
... promising new technique to ensure complete tumor removal at ... of Radiology. , Researchers used light waves in a ... examine excised breast tissue and determine if the removed ... This technology has the potential to eliminate the need ...
... different species, evolution whizzes along. As different species ... environment and prosper. It happens in marine sediments, ... in precancerous tumors, too. , In a study ... Ph.D., a researcher at The Wistar Institute, and ...
... a natural mechanism to get inside cells and grow, researchers ... millions of receptors on the cell's surface routinely do after ... Chair in Oncologic Pathology at the Medical College of Georgia. ... 23 by Proceedings of the National Academy of Sciences. , ...
Cached Biology News:Terahertz imaging may reduce breast cancer surgeries 2Researchers create pigs that produce heart-healthy omega-3 fatty acids 2Common bacteria pirate natural mechanism to get inside cells 2
Request Info...
... Concentration Basement Membrane Extract Cultrex HC20+ ... vivo applications where higher protein concentrations ... strength, and elevated levels of tumor ... of lot-to-lot consistency and controlled protein ...
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis *2 mg/mL*...
...
Biology Products: